Navigation Links
Nfocus Neuromedical Elects Eric P. Milledge Chairman of Board
Date:4/30/2009

Milledge brings proven experience, dynamic insights and strategic focus to neurovascular interventions developer.

PALO ALTO, Calif., April 30 /PRNewswire/ -- Nfocus Neuromedical Inc. announced today that its directors elected Eric P. Milledge as Chairman of the Board. "Mr. Milledge brings exceptional industry experience, business acumen and leadership to Nfocus, as we advance our pursuit of break-through technologies in the dynamic field of endovascular neurosurgery," noted President and CEO Martin S. Dieck.

"The relevance of Milledge's 34 years of experience with Johnson & Johnson is what attracted us to him. Most recently serving as Company Group Chairman for the LifeScan division of Johnson & Johnson and as a member of the J&J Medical Devices & Diagnostics Group Operating Committee, Milledge will prove invaluable in strategically guiding us through our development, regulatory approval and commercialization process."

"Neurovascular disease is one of the leading causes of death and disability and is still widely underserved. I am impressed with the potential of the technological advances Nfocus brings to this medical field," said Milledge. "It is an honor and a privilege to work with the Nfocus team in bringing surgeons simpler, less invasive devices that could change the lives of millions through improved endovascular surgery outcomes."

Milledge began with J&J in 1973. He later held positions of Company Group Chairman of Johnson & Johnson Health Care Systems, Inc., President of Ortho-McNeil, and President of Ortho Pharmaceutical Corporation.

"Nfocus has its hand on the pulse of the dynamic developments in the emerging endovascular neurosurgery field," added Milledge. "It's an exciting time to add strategic guidance, which can further the advancement of our product technologies."

About Nfocus Neuromedical, Inc.

Nfocus is positioning itself to be the world-wide leader in the development of next-generation endovascular neurosurgery solutions (surgery through less-invasive catheter devices). Backed by premier venture investors, the Company is developing revolutionary systems to treat neurovascular disease, including brain aneurysms, that are simple, safe, cost-effective and curative.

Nfocus was incubated at In-Cube Labs and is backed by Oxford Bioscience Partners, Technology Partners and DFJ-ePlanet Ventures.

To learn more about the Nfocus Neuromedical development programs focused on providing faster, simpler and more permanent treatment of vascular diseases of the brain and spine, please visit the new Nfocus website at: www.nfocusneuro.com.

For more information about aneurysms and hemorrhagic stroke see: www.strokeassociation.org and www.snisonline.org


'/>"/>
SOURCE Nfocus Neuromedical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
2. Nfocus Neuromedical Announces Acquisition of StarFire Medical
3. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
4. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
5. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
6. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
7. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
8. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
9. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
10. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
11. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: